-
1
-
-
0033975038
-
Mechanistic aspects of the cytotoxic activity of glufosfamide, a new tumour therapeutic agent
-
10.1054/bjoc.1999.0974 1:CAS:528:DC%2BD3cXht1eisb8%3D 10682676
-
H Seker B Bertram A Burkle B Kaina J Pohl H Koepsell M Wiesser 2000 Mechanistic aspects of the cytotoxic activity of glufosfamide, a new tumour therapeutic agent Br J Cancer 82 3 629 634 10.1054/bjoc.1999.0974 1:CAS:528:DC%2BD3cXht1eisb8%3D 10682676
-
(2000)
Br J Cancer
, vol.82
, Issue.3
, pp. 629-634
-
-
Seker, H.1
Bertram, B.2
Burkle, A.3
Kaina, B.4
Pohl, J.5
Koepsell, H.6
Wiesser, M.7
-
2
-
-
34247331011
-
Design of new oxazaphosphorine anticancer drugs
-
DOI 10.2174/138161207780414296
-
J Liang M Huang W Duan XQ Yu S Zhou 2007 Design of new oxazaphosphorine anticancer drugs Curr Pharm Des 13 9 963 978 10.2174/138161207780414296 1:CAS:528:DC%2BD2sXmtVWmurY%3D 17430192 (Pubitemid 46628292)
-
(2007)
Current Pharmaceutical Design
, vol.13
, Issue.9
, pp. 963-978
-
-
Liang, J.1
Huang, M.2
Duan, W.3
Yu, X.-Q.4
Zhou, S.5
-
3
-
-
0030023026
-
Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers
-
1:CAS:528:DyaK28XhtlKkt7o%3D 8640778
-
M Younes LV Lechago JR Somoano M Mosharaf J Lechago 1996 Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers Cancer Res 56 5 1164 1167 1:CAS:528:DyaK28XhtlKkt7o%3D 8640778
-
(1996)
Cancer Res
, vol.56
, Issue.5
, pp. 1164-1167
-
-
Younes, M.1
Lechago, L.V.2
Somoano, J.R.3
Mosharaf, M.4
Lechago, J.5
-
4
-
-
0025075721
-
Over-expression of facilitative glucose transporter genes in human cancer
-
DOI 10.1016/0006-291X(90)91263-R
-
T Yamamoto Y Seino H Fukumoto G Koh H Yano N Inagaki Y Yamada K Inoue T Manabe H Imura 1990 Over-expression of facilitative glucose transporter genes in human cancer Biochem Biophys Res Commun 170 1 223 230 10.1016/0006-291X(90) 91263-R 1:CAS:528:DyaK3cXltFeisLk%3D 2372287 (Pubitemid 20249408)
-
(1990)
Biochemical and Biophysical Research Communications
, vol.170
, Issue.1
, pp. 223-230
-
-
Yamamoto, T.1
Seino, Y.2
Fukumoto, H.3
Kohb, G.4
Yano, H.5
Inagaki, N.6
Yamada, Y.7
Inoue, K.8
Manabe, T.9
Imura, H.10
-
5
-
-
0032539859
-
+-D-glucose cotransporter SAAT1
-
DOI 10.1073/pnas.95.6.2914
-
M Veyhl K Wagner C Volk V Gorboulev K Baumgarten WM Weber M Schaper B Bertram M Wiessler H Koepsell 1998 Transport of the new chemotherapeutic agent beta-d-glucosylisophosphoramide mustard (d-19575) into tumor cells is mediated by the Na+-d-glucose cotransporter SAAT1 Proc Natl Acad Sci USA 95 6 2914 2919 10.1073/pnas.95.6.2914 1:CAS:528:DyaK1cXitV2is7o%3D 9501190 (Pubitemid 28135829)
-
(1998)
Proceedings of the National Academy of Sciences of the United States of America
, vol.95
, Issue.6
, pp. 2914-2919
-
-
Veyhl, M.1
Wagner, K.2
Volk, C.3
Gorboulev, V.4
Baumgarten, K.5
Weber W.-, M.6
Schaper, M.7
Bertram, B.8
Wiessler, M.9
Koepsell, H.10
-
6
-
-
0027505293
-
Cloning and expression of a mammalian Na+/amino acid cotransporter with sequence similarity to Na+/glucose cotransporters
-
1:CAS:528:DyaK3sXit1ymsLo%3D 8420925
-
CT Kong SF Yet JE Lever 1993 Cloning and expression of a mammalian Na+/amino acid cotransporter with sequence similarity to Na+/glucose cotransporters J Biol Chem 268 3 1509 1512 1:CAS:528:DyaK3sXit1ymsLo%3D 8420925
-
(1993)
J Biol Chem
, vol.268
, Issue.3
, pp. 1509-1512
-
-
Kong, C.T.1
Yet, S.F.2
Lever, J.E.3
-
7
-
-
0028021758
-
SAAT1 is a low affinity Na+/glucose cotransporter and not an amino acid transporter. A reinterpretation
-
1:CAS:528:DyaK2cXlvFylurg%3D 8077195
-
B Mackenzie M Panayotova-Heiermann DD Loo JE Lever EM Wright 1994 SAAT1 is a low affinity Na+/glucose cotransporter and not an amino acid transporter. A reinterpretation J Biol Chem 269 36 22488 22491 1:CAS:528:DyaK2cXlvFylurg%3D 8077195
-
(1994)
J Biol Chem
, vol.269
, Issue.36
, pp. 22488-22491
-
-
MacKenzie, B.1
Panayotova-Heiermann, M.2
Loo, D.D.3
Lever, J.E.4
Wright, E.M.5
-
8
-
-
0029679705
-
3H]-thymidine in various tissues of the rat
-
DOI 10.1007/s002800050495
-
J Stuben R Port B Bertram U Bollow WE Hull M Schaper J Pohl M Wiessler 1996 Pharmacokinetics and whole-body distribution of the new chemotherapeutic agent beta-d-glucosylisophosphoramide mustard and its effects on the incorporation of [methyl-3H]-thymidine in various tissues of the rat Cancer Chemother Pharmacol 38 4 355 365 10.1007/s002800050495 1:STN:280: DyaK283osFGrug%3D%3D 8674159 (Pubitemid 26226302)
-
(1996)
Cancer Chemotherapy and Pharmacology
, vol.38
, Issue.4
, pp. 355-365
-
-
Stuben, J.1
Port, R.2
Bertram, B.3
Bollow, U.4
Hull, W.E.5
Schaper, M.6
Pohl, J.7
Wiessler, M.8
-
9
-
-
59649125837
-
New ifosfamide analogues designed for lower associated neurotoxicity and nephrotoxicity with modified alkylating kinetics leading to enhanced in vitro anticancer activity
-
10.1124/jpet.108.144170 1:CAS:528:DC%2BD1MXhs1Kgsrg%3D 19017849
-
T Storme A Deroussent L Mercier E Prost M Re F Munier T Martens P Bourget G Vassal J Royer 2009 New ifosfamide analogues designed for lower associated neurotoxicity and nephrotoxicity with modified alkylating kinetics leading to enhanced in vitro anticancer activity J Pharmacol Exp Ther 328 2 598 609 10.1124/jpet.108.144170 1:CAS:528:DC%2BD1MXhs1Kgsrg%3D 19017849
-
(2009)
J Pharmacol Exp Ther
, vol.328
, Issue.2
, pp. 598-609
-
-
Storme, T.1
Deroussent, A.2
Mercier, L.3
Prost, E.4
Re, M.5
Munier, F.6
Martens, T.7
Bourget, P.8
Vassal, G.9
Royer, J.10
-
10
-
-
0141594797
-
Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development group
-
DOI 10.1016/S0959-8049(03)00629-4
-
E Briasoulis N Pavlidis C Terret J Bauer W Fiedler P Schoffski JL Raoul D Hess R Selvais D Lacombe 2003 Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development group Eur J Cancer 39 16 2334 2340 10.1016/S0959-8049(03)00629-4 1:CAS:528:DC%2BD3sXnvVymtbY%3D 14556925 (Pubitemid 37214857)
-
(2003)
European Journal of Cancer
, vol.39
, Issue.16
, pp. 2334-2340
-
-
Briasoulis, E.1
Pavlidis, N.2
Terret, C.3
Bauer, J.4
Fiedler, W.5
Schoffski, P.6
Raoul, J.-L.7
Hess, D.8
Selvais, R.9
Lacombe, D.10
Bachmann, P.11
Fumoleau, P.12
-
11
-
-
12144285603
-
Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer: A phase II trial of the EORTC-New Drug Development Group
-
DOI 10.1016/j.ejca.2003.10.027, PII S0959804903010232
-
G Giaccone EF Smit M de Jonge E Dansin E Briasoulis A Ardizzoni JY Douillard D Spaeth D Lacombe B Baron 2004 Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development Group Eur J Cancer 40 5 667 672 10.1016/j.ejca.2003.10.027 1:CAS:528:DC%2BD2cXhvVOrt7c%3D 15010066 (Pubitemid 38326615)
-
(2004)
European Journal of Cancer
, vol.40
, Issue.5
, pp. 667-672
-
-
Giaccone, G.1
Smit, E.F.2
De Jonge, M.3
Dansin, E.4
Briasoulis, E.5
Ardizzoni, A.6
Douillard, J.-Y.7
Spaeth, D.8
Lacombe, D.9
Baron, B.10
Bachmann, P.11
Fumoleau, P.12
-
12
-
-
0034667838
-
Phase i trial of 6-h infusion of glufosfamide, a new alkylating agent with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters: A study of the European Organization for Research and Treatment of Cancer Early Clinical Studies Group
-
1:CAS:528:DC%2BD3cXnvV2kurk%3D 11032596
-
E Briasoulis I Judson N Pavlidis P Beale J Wanders Y Groot G Veerman M Schuessler G Niebch K Siamopoulos 2000 Phase I trial of 6-h infusion of glufosfamide, a new alkylating agent with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters: a study of the European Organization for Research and Treatment of Cancer Early Clinical Studies Group J Clin Oncol 18 20 3535 3544 1:CAS:528:DC%2BD3cXnvV2kurk%3D 11032596
-
(2000)
J Clin Oncol
, vol.18
, Issue.20
, pp. 3535-3544
-
-
Briasoulis, E.1
Judson, I.2
Pavlidis, N.3
Beale, P.4
Wanders, J.5
Groot, Y.6
Veerman, G.7
Schuessler, M.8
Niebch, G.9
Siamopoulos, K.10
-
13
-
-
19944428423
-
Comparative preclinical toxicology and pharmacology of isophosphoramide mustard, the active metabolite of ifosfamide
-
DOI 10.1007/s00280-004-0894-y
-
N Germann S Urien AH Rodgers M Ratterree RF Struck WR Waud DG Serota G Bastian BS Jursic LR Morgan 2005 Comparative preclinical toxicology and pharmacology of isophosphoramide mustard, the active metabolite of ifosfamide Cancer Chemother Pharmacol 55 2 143 151 10.1007/s00280-004-0894-y 1:CAS:528:DC%2BD2cXhtVGgtLzJ 15592722 (Pubitemid 40110057)
-
(2005)
Cancer Chemotherapy and Pharmacology
, vol.55
, Issue.2
, pp. 143-151
-
-
Germann, N.1
Urien, S.2
Rodgers, A.H.3
Ratterree, M.4
Struck, R.F.5
Waud, W.R.6
Serota, D.G.7
Bastian, G.8
Jursic, B.S.9
Morgan, L.R.10
-
14
-
-
0034053590
-
Metabolism and pharmacokinetics of oxazaphosphorines
-
10.2165/00003088-200038040-00001 1:CAS:528:DC%2BD3cXjtlKku7s%3D 10803453
-
AV Boddy SM Yule 2000 Metabolism and pharmacokinetics of oxazaphosphorines Clin Pharmacokinet 38 4 291 304 10.2165/00003088-200038040- 00001 1:CAS:528:DC%2BD3cXjtlKku7s%3D 10803453
-
(2000)
Clin Pharmacokinet
, vol.38
, Issue.4
, pp. 291-304
-
-
Boddy, A.V.1
Yule, S.M.2
-
15
-
-
0029011183
-
Comparison of continuous infusion and bolus administration of ifosfamide in children
-
10.1016/0959-8049(95)00090-6 1:STN:280:DyaK2MzmsleitA%3D%3D 7640054
-
AV Boddy SM Yule R Wyllie L Price AD Pearson JR Idle 1995 Comparison of continuous infusion and bolus administration of ifosfamide in children Eur J Cancer 31A 5 785 790 10.1016/0959-8049(95)00090-6 1:STN:280:DyaK2MzmsleitA%3D%3D 7640054
-
(1995)
Eur J Cancer
, vol.31
, Issue.5
, pp. 785-790
-
-
Boddy, A.V.1
Yule, S.M.2
Wyllie, R.3
Price, L.4
Pearson, A.D.5
Idle, J.R.6
-
16
-
-
0029891049
-
Glucose catabolism in cancer cells: Amplification of the gene encoding type II hexokinase
-
A Rempel SP Mathupala CA Griffin AL Hawkins PL Pedersen 1996 Glucose catabolism in cancer cells: amplification of the gene encoding type II hexokinase Cancer Res 56 11 2468 2471 1:CAS:528:DyaK28XjtlCgt7c%3D 8653677 (Pubitemid 26170674)
-
(1996)
Cancer Research
, vol.56
, Issue.11
, pp. 2468-2471
-
-
Rempel, A.1
Mathupala, S.P.2
Griffin, C.A.3
Hawkins, A.L.4
Pedersen, P.L.5
-
17
-
-
0019977934
-
Glucose turnover, gluconeogenesis from glycerol, and estimation of net glucose cycling in cancer patients
-
DOI 10.1002/1097-0142(19820915)50:6<1142::AID-CNCR2820500618>3.0. CO;2-I
-
K Lundholm S Edstrom I Karlberg L Ekman T Schersten 1982 Glucose turnover, gluconeogenesis from glycerol, and estimation of net glucose cycling in cancer patients Cancer 50 6 1142 1150 10.1002/1097-0142(19820915)50: 6<1142::AID-CNCR2820500618>3.0.CO;2-I 1:STN:280:DyaL383lvVyitw%3D%3D 7104955 (Pubitemid 12062893)
-
(1982)
Cancer
, vol.50
, Issue.6
, pp. 1142-1150
-
-
Lundholm, K.1
Edstrom, S.2
Karlberg, I.3
-
18
-
-
0026770338
-
Glucose transporters
-
10.1146/annurev.me.43.020192.002113 1:CAS:528:DyaK38XkvVOmtb0%3D 1580597
-
LJ Elsas N Longo 1992 Glucose transporters Annu Rev Med 43 377 393 10.1146/annurev.me.43.020192.002113 1:CAS:528:DyaK38XkvVOmtb0%3D 1580597
-
(1992)
Annu Rev Med
, vol.43
, pp. 377-393
-
-
Elsas, L.J.1
Longo, N.2
-
19
-
-
0027948971
-
Molecular physiology of sodium-glucose cotransporters
-
1:CAS:528:DyaK2MXitFGnsLs%3D 7938229
-
MA Hediger DB Rhoads 1994 Molecular physiology of sodium-glucose cotransporters Physiol Rev 74 4 993 1026 1:CAS:528:DyaK2MXitFGnsLs%3D 7938229
-
(1994)
Physiol Rev
, vol.74
, Issue.4
, pp. 993-1026
-
-
Hediger, M.A.1
Rhoads, D.B.2
-
20
-
-
0027489912
-
Overexpression of Glut-1 glucose transporter in human breast cancer: An immunohistochemical study
-
DOI 10.1002/1097-0142(19931115)72:10<2979::AID-CNCR2820721020>3.0. CO;2-X
-
RS Brown RL Wahl 1993 Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study Cancer 72 10 2979 2985 10.1002/1097-0142(19931115)72:10<2979::AID-CNCR2820721020>3.0.CO;2-X 1:STN:280:DyaK2c%2Fjs1KqtA%3D%3D 8221565 (Pubitemid 23335044)
-
(1993)
Cancer
, vol.72
, Issue.10
, pp. 2979-2985
-
-
Brown, R.S.1
Wahl, R.L.2
-
21
-
-
0031825144
-
Role for glucose transporter 1 protein in human breast cancer
-
10.1007/BF02904704 1:CAS:528:DyaK1cXlvFOmsLk%3D 9654596
-
M Grover-McKay SA Walsh EA Seftor PA Thomas MJ Hendrix 1998 Role for glucose transporter 1 protein in human breast cancer Pathol Oncol Res 4 2 115 120 10.1007/BF02904704 1:CAS:528:DyaK1cXlvFOmsLk%3D 9654596
-
(1998)
Pathol Oncol Res
, vol.4
, Issue.2
, pp. 115-120
-
-
Grover-Mckay, M.1
Walsh, S.A.2
Seftor, E.A.3
Thomas, P.A.4
Hendrix, M.J.5
-
22
-
-
0032125565
-
GLUT1 glucose transporter expression in colorectal carcinoma: A marker for poor prognosis
-
DOI 10.1002/(SICI)1097-0142(19980701)83:1<34::AID-CNCR5>3.0.CO;2-E
-
RS Haber A Rathan KR Weiser A Pritsker SH Itzkowitz C Bodian G Slater A Weiss DE Burstein 1998 GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis Cancer 83 1 34 40 10.1002/(SICI)1097- 0142(19980701)83:1<34::AID-CNCR5>3.0.CO;2-E 1:CAS:528:DyaK1cXktlejsbw%3D 9655290 (Pubitemid 28299626)
-
(1998)
Cancer
, vol.83
, Issue.1
, pp. 34-40
-
-
Haber, R.S.1
Rathan, A.2
Weiser, K.R.3
Pritsker, A.4
Itzkowitz, S.H.5
Bodian, C.6
Slater, G.7
Weiss, A.8
Burstein, D.E.9
-
23
-
-
33846942624
-
Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-d-glucose uptake by positron emission tomography in colorectal cancer
-
10.1007/s10620-006-9428-2 1:CAS:528:DC%2BD2sXktFCktA%3D%3D 17080242
-
J Gu H Yamamoto H Fukunaga K Danno I Takemasa M Ikeda M Tatsumi M Sekimoto J Hatazawa T Nishimura 2006 Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-d-glucose uptake by positron emission tomography in colorectal cancer Dig Dis Sci 51 12 2198 2205 10.1007/s10620-006-9428-2 1:CAS:528:DC%2BD2sXktFCktA%3D%3D 17080242
-
(2006)
Dig Dis Sci
, vol.51
, Issue.12
, pp. 2198-2205
-
-
Gu, J.1
Yamamoto, H.2
Fukunaga, H.3
Danno, K.4
Takemasa, I.5
Ikeda, M.6
Tatsumi, M.7
Sekimoto, M.8
Hatazawa, J.9
Nishimura, T.10
-
24
-
-
33845654267
-
Evaluation of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography in gastric carcinoma: Relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression
-
10.1007/BF02984657 1:CAS:528:DC%2BD2sXhvFyktrw%3D 17294670
-
A Yamada K Oguchi M Fukushima Y Imai M Kadoya 2006 Evaluation of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression Ann Nucl Med 20 9 597 604 10.1007/BF02984657 1:CAS:528:DC%2BD2sXhvFyktrw%3D 17294670
-
(2006)
Ann Nucl Med
, vol.20
, Issue.9
, pp. 597-604
-
-
Yamada, A.1
Oguchi, K.2
Fukushima, M.3
Imai, Y.4
Kadoya, M.5
-
25
-
-
0030160492
-
Intratumoral distribution of tritiated-FDG in breast carcinoma: Correlation between Glut-1 expression and FDG uptake
-
1:STN:280:DyaK28zgtVersw%3D%3D 8683298
-
RS Brown JY Leung SJ Fisher KA Frey SP Ethier RL Wahl 1996 Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake J Nucl Med 37 6 1042 1047 1:STN:280: DyaK28zgtVersw%3D%3D 8683298
-
(1996)
J Nucl Med
, vol.37
, Issue.6
, pp. 1042-1047
-
-
Brown, R.S.1
Leung, J.Y.2
Fisher, S.J.3
Frey, K.A.4
Ethier, S.P.5
Wahl, R.L.6
-
26
-
-
0032940031
-
Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer
-
1:STN:280:DyaK1M3isV2iuw%3D%3D 10210213
-
RS Brown JY Leung PV Kison KR Zasadny A Flint RL Wahl 1999 Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer J Nucl Med 40 4 556 565 1:STN:280:DyaK1M3isV2iuw%3D%3D 10210213
-
(1999)
J Nucl Med
, vol.40
, Issue.4
, pp. 556-565
-
-
Brown, R.S.1
Leung, J.Y.2
Kison, P.V.3
Zasadny, K.R.4
Flint, A.5
Wahl, R.L.6
|